SKK
TNDM icon

Shepherd Kaplan Krochuk’s Tandem Diabetes Care TNDM Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,193
Closed -$133K – 265
2017
Q3 		$133K Buy
+18,193
New +$115K 0.11% 174
2017
Q1 		– Sell
-2,887
Closed -$62K – 283
2016
Q4 		$62K Sell
2,887
-675
-19% -$26K 0.02% 251
2016
Q3 		$273K Hold
3,562
– – 0.06% 211
2016
Q2 		$269K Hold
3,562
– – 0.07% 204
2016
Q1 		$310K Buy
3,562
+1,432
+67% +$125K 0.1% 162
2015
Q4 		$252K Sell
2,130
-1,536
-42% -$152K 0.07% 225
2015
Q3 		$323K Buy
3,666
+1,443
+65% +$168K 0.09% 176
2015
Q2 		$241K Hold
2,223
– – 0.05% 270
2015
Q1 		$281K Sell
2,223
-1,273
-36% -$166K 0.05% 250
2014
Q4 		$444K Hold
3,496
– – 0.07% 222
2014
Q3 		$469K Sell
3,496
-606
-15% -$84.9K 0.06% 220
2014
Q2 		$667K Buy
4,102
+2,735
+200% +$465K 0.07% 181
2014
Q1 		$302K Buy
+1,367
New +$349K 0.03% 307

Other funds holding TNDM

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Shepherd Kaplan Krochuk's TNDM Position: Q4 2017 in Review

Shepherd Kaplan Krochuk sold out of Tandem Diabetes Care (TNDM) in Q4 2017, closing a stake of 18,193 shares — an estimated $133K sold.

Shepherd Kaplan Krochuk first reported a position in TNDM in Q1 2014 and held it in 13 quarters. The position peaked at $667K in Q2 2014. 42 funds tracked by Wall St. Rank hold TNDM as of Q4 2017.

  • Shepherd Kaplan Krochuk reported no remaining Tandem Diabetes Care position as of Q4 2017 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 18,193 Tandem Diabetes Care shares in Q4 2017, an estimated $133K.
  • Shepherd Kaplan Krochuk first reported a position in Tandem Diabetes Care in Q1 2014 and held it in 13 quarters.
  • Shepherd Kaplan Krochuk's Tandem Diabetes Care position peaked at $667K in Q2 2014.
  • 42 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2017, filed 13 Feb 2018.